Cargando…
Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort
Despite the wide use of 5-fluorouracil-based chemotherapy, development of severe toxicity that follow the treatment is not a rare event. The efforts to establish pretreatment tools for toxicity prediction, led to the development of various pharmacogenetic and biochemical assays, mainly targeted to a...
Autores principales: | Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Mazzotti, Eva, Marchetti, Luca, Gentile, Giovanna, La Torre, Marco, Lionetto, Luana, Simmaco, Maurizio, Marchetti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991479/ https://www.ncbi.nlm.nih.gov/pubmed/26967565 http://dx.doi.org/10.18632/oncotarget.7991 |
Ejemplares similares
-
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
por: Borro, Marina, et al.
Publicado: (2016) -
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
por: Botticelli, Andrea, et al.
Publicado: (2016) -
Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy
por: Mazzuca, Federica, et al.
Publicado: (2015) -
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?
por: Botticelli, Andrea, et al.
Publicado: (2015) -
Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
por: De Luca, Ottavia, et al.
Publicado: (2022)